Stefan J. Cross
Keine laufenden Positionen mehr
Profil
Stefan J.
Cross served as Director at Inhibitor Therapeutics, Inc. from 2014 to 2022.
Prior to that, he was Head-Marketing Asia Pacific Region at Hospira, Inc. from 2007 to 2012.
From 2012 to 2017, he served as President at Mayne Pharma, Inc. and later as President at Mayne Pharma (USA), Inc. He also served as President-International Operations at Mayne Pharma Group Ltd.
from 2017 to 2023.
Mr. Cross received his undergraduate degree from the University of South Australia and his MBA from Swinburne University of Technology.
Ehemalige bekannte Positionen von Stefan J. Cross
| Unternehmen | Position | Ende |
|---|---|---|
| MAYNE PHARMA GROUP LIMITED | Corporate Officer/Principal | 01.01.2023 |
| INHIBITOR THERAPEUTICS, INC. | Director/Board Member | 13.12.2022 |
Mayne Pharma, Inc.
 Mayne Pharma, Inc. Pharmaceuticals: MajorHealth Technology Mayne Pharma, Inc. develops pharmaceutical products. Its services include pharmaceutical development, clinical trial materials, method development and validation, trace metals, stability, and microbiology services. The company was founded in 1994 and is headquartered in Greenville, NC. | President | 01.01.2017 |
| HOSPIRA, INC. | Sales & Marketing | 01.01.2012 |
Mayne Pharma (USA), Inc.
 Mayne Pharma (USA), Inc. Pharmaceuticals: MajorHealth Technology Mayne Pharma (USA), Inc. supplies injectable pharmaceuticals. Its products cover a range of therapeutic categories including oncology, pain management and cardiac care. The company was founded in 1995 and is headquartered in Paramus, NJ. | President | - |
Ausbildung von Stefan J. Cross
| University of South Australia | Undergraduate Degree |
| Swinburne University of Technology | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MAYNE PHARMA GROUP LIMITED | Health Technology |
| INHIBITOR THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
Mayne Pharma, Inc.
Mayne Pharma, Inc. Pharmaceuticals: MajorHealth Technology Mayne Pharma, Inc. develops pharmaceutical products. Its services include pharmaceutical development, clinical trial materials, method development and validation, trace metals, stability, and microbiology services. The company was founded in 1994 and is headquartered in Greenville, NC. | Health Technology |
Mayne Pharma (USA), Inc.
Mayne Pharma (USA), Inc. Pharmaceuticals: MajorHealth Technology Mayne Pharma (USA), Inc. supplies injectable pharmaceuticals. Its products cover a range of therapeutic categories including oncology, pain management and cardiac care. The company was founded in 1995 and is headquartered in Paramus, NJ. | Health Technology |
